Vaginal Hysterectomy Versus Laparoscopically Assisted Vaginal Hysterectomy for Large Uteri

Sponsor
Ain Shams Maternity Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02826304
Collaborator
(none)
50
1
2
23
2.2

Study Details

Study Description

Brief Summary

The investigators compare between Vaginal Hysterectomy and Laparoscopically assisted vaginal hysterectomy in cases of large uteri weighing more than 280 gm regarding operative and Postoperative outcomes

Condition or Disease Intervention/Treatment Phase
  • Procedure: Vaginal hysterectomy
  • Procedure: Laparoscopic assisted vaginal hysterectomy
N/A

Detailed Description

Study setting : Ain Shams University Maternity Hospital Study Design : Pilot prospective randomized clinical trial Study population: The patients will be recruited from women presenting to the outpatient clinic of Ain Shams University Maternity Hospital planned to undergo hysterectomy for benign cause according to inclusion/ exclusion criteria which will be mentioned later.

Study duration : the study will be carried out during the period from August 2014 to August 2016.

Sample size: total of 50 cases will be included in the study to be divided into two groups, the first group will undergo vaginal hysterectomy and the second will undergo Laparoscopic assisted vaginal hysterectomy.

intervention: after approval of the ethical committee, a detailed explanation of the procedure will be informed to the participant and after her approval to involve in the study, an informed written consent will be taken. Detailed medical history will be obtained from all participants recruited in the study along with complete clinical examination and necessary laboratory and radiological investigations. Each patient will have a case record form in which the data regarding history, examination, investigations, operation costs and postoperative events will be recorded

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Vaginal Hysterectomy Versus Laparoscopically Assisted Hysterectomy for Large Uteri ( A Pilot Randomized Clinical Trial)
Study Start Date :
Aug 1, 2014
Actual Primary Completion Date :
May 1, 2016
Anticipated Study Completion Date :
Jul 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: VH

Vaginal Hysterectomy for uteri larger than 280gm

Procedure: Vaginal hysterectomy
All the cases were performed by the same surgical team Incision is made at the anterior cervical lip below the bladder reflection Anterior peritoneal entry . Douglas pouch entry. The uterosacral ligaments and the cardinal ligaments are clamped, divided and ligated . Uterine artery clamping division and ligation After securing the uterine A., debulking procedures was performed in the form of bisection, coring or myomectomy Utero-ovarian and round clamping-division and ligation ( in cases where oophorectomy was performed this part was done at the level of the infundibulo-pelvic ligament). Hemostasis The vaginal vault is closed after insertion of intraperitoneal drain and

Active Comparator: LAVH

Laparoscopic assisted vaginal hysterectomy for uteri larger than 280gm

Procedure: Laparoscopic assisted vaginal hysterectomy
Uterine manipulator was inserted through the cervix to mobilize the uterus Veress needle was inserted through the base of the umbilicus creation of pneumoperitoneum Insertion of 4 trocars one at the base of umbilicus for the camera and 3 lateral trocars The round and the utero-ovarian ligament are coagulated and divided. Dissection through the vesico-uterine space to displace bladder away from the cervix. Uterine artery was coagulated and divided laparoscopically anterior colpotomy over the cup of the uterine elevator. Vaginal part starts with opening of douglas pouch and clamping , division and ligation of uterosacral and cardinal ligaments followed by removal of the uterus and closure of the vault. reinflation to ensure proper hemostasis.

Outcome Measures

Primary Outcome Measures

  1. Operative time of the procedure [Range from 90 minutes to 210 minutes]

    In case of vaginal hysterectomy, the operative time will be measured from the vaginal incision to closure of the vaginal vault. in cases of Laparoscopic assisted vaginal hysterectomy, the time will be measured from the introduction of the laparoscopic camera port till stitching the laparoscopic incisions after ensuring adequate hemostasis. the time of any concomitant procedures was excluded

Secondary Outcome Measures

  1. Estimated intraoperative blood loss [the operative time of the procedure which range from 90 minutes to 210 minutes]

    intraoperative blood loss will be estimated via: - amount of blood in suction bottle. - Estimation based on number of soaked gauzes by weighing the gauzes used in the procedure before and after surgery ( each 1mg corresponds to 1ml of blood) - Drop in postoperative hemoglobin and hematocrit when compared with preoperative values.

  2. Hospital costs [within the period of hospital admission which range from 2 to 8 days]

    the costs of the following will be calculated: - Admission cost which include ward fee, pre and postoperative management costs and extra charges for post surgical complication. - anesthesia cost which includes expenses of anesthetics during the procedure. C)- operation cost which include operative material fee.

  3. intraoperative complications [the operative time of the procedure which range from 90 minutes to 210 minutes]

    - need for blood transfusion - need for laparotomy due to either surgical difficulty or any complication - Bowel or urinary tract injuries

  4. Postoperative Pain [the first 24hrs after the procedure]

    Postoperative pain will be assessed using the visual analogue scale after the procedure by 6hrs, 12hrs and 24hrs.

  5. Postoperative complications [1 month after the procedure]

    - Need for blood transfusion - Vaginal vault or pelvic hematoma - surgical site infection - urinary tract infection - postoperative bowel or urinary tract complications

  6. postoperative hospital stay [range from 24 hours to 168 hours]

    the hospital stay will be measured in hours

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age between 40 and 70 years.

  2. Uterine weight more than 280gm. the weight will be estimated sonographically using algebraic formula by Kung and Chang expressed in weights and measurements: weight(g)= 50+(4/3 x π(Pi) x L/2 x W/2 x AP/2) where (L) is the length of the uterus from the dome of the fundus to the level of the external os and (W) is the maximum width of the uterus at the level of the cornua and (AP) is the anteroposterior diameter of the uterus . Both (W) and (AP) will be taken perpendicular to the axis of the uterine length.

  3. Presence of a benign cause for hysterectomy. e.g: fibroid uterus, simple endometrial hyperplasia not responding to medical treatment and adenomyosis.

Exclusion Criteria:
  1. Patients medically unfit for laparoscopy as severely compromised cardiac patients.

  2. Obese patients (BMI>30).

  3. Presence of endometriosis.

  4. Previous myomectomy

  5. Presence of adnexal mass

  6. Known or suspected gynecological malignancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maternity hospital, Ain Shams University Cairo Egypt

Sponsors and Collaborators

  • Ain Shams Maternity Hospital

Investigators

  • Study Chair: Fekrya A Salama, PhD, Ain Shams University Maternity Hospital
  • Study Director: Ahmed A Tharwat, PhD, Ain Shams University Maternity Hospital
  • Study Director: Walid E Mohamed, PhD, Ain Shams University Maternity Hospital
  • Study Director: Ibrahim M Ibrahim, PhD, Ain Shams University Maternity Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ibrahim Mohamed Ibrahim Ali, lecturer in obstetrics and gynecology, Ain Shams Maternity Hospital
ClinicalTrials.gov Identifier:
NCT02826304
Other Study ID Numbers:
  • 1
First Posted:
Jul 7, 2016
Last Update Posted:
Jul 11, 2016
Last Verified:
Jul 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Ibrahim Mohamed Ibrahim Ali, lecturer in obstetrics and gynecology, Ain Shams Maternity Hospital

Study Results

No Results Posted as of Jul 11, 2016